EA201390764A1 - Фармацевтические композиции - Google Patents

Фармацевтические композиции

Info

Publication number
EA201390764A1
EA201390764A1 EA201390764A EA201390764A EA201390764A1 EA 201390764 A1 EA201390764 A1 EA 201390764A1 EA 201390764 A EA201390764 A EA 201390764A EA 201390764 A EA201390764 A EA 201390764A EA 201390764 A1 EA201390764 A1 EA 201390764A1
Authority
EA
Eurasian Patent Office
Prior art keywords
pharmaceutical compositions
prophylaxis
administration
risk
reduction
Prior art date
Application number
EA201390764A
Other languages
English (en)
Other versions
EA027791B1 (ru
Inventor
Данпин Ли
Original Assignee
Риб-Экс Фармасьютикалз, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Риб-Экс Фармасьютикалз, Инк. filed Critical Риб-Экс Фармасьютикалз, Инк.
Publication of EA201390764A1 publication Critical patent/EA201390764A1/ru
Publication of EA027791B1 publication Critical patent/EA027791B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4192—1,2,3-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Abstract

Настоящее изобретение относится к фармацевтическим композициям, применимым для введения для лечения, профилактики или снижения риска микробных инфекций.
EA201390764A 2010-11-24 2011-11-21 Фармацевтические композиции EA027791B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41680710P 2010-11-24 2010-11-24
PCT/US2011/061643 WO2012071324A2 (en) 2010-11-24 2011-11-21 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
EA201390764A1 true EA201390764A1 (ru) 2013-09-30
EA027791B1 EA027791B1 (ru) 2017-09-29

Family

ID=46146374

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201390764A EA027791B1 (ru) 2010-11-24 2011-11-21 Фармацевтические композиции

Country Status (20)

Country Link
US (2) US20140088164A1 (ru)
EP (1) EP2642996B1 (ru)
JP (2) JP6370550B2 (ru)
KR (1) KR101944124B1 (ru)
CN (1) CN103391778B (ru)
AU (1) AU2011332031B2 (ru)
BR (1) BR112013012833A8 (ru)
CA (1) CA2818249C (ru)
EA (1) EA027791B1 (ru)
ES (1) ES2836809T3 (ru)
HU (1) HUE052801T2 (ru)
IL (1) IL226378A0 (ru)
MX (1) MX350565B (ru)
MY (2) MY182136A (ru)
NZ (1) NZ610638A (ru)
PT (1) PT2642996T (ru)
SG (2) SG190354A1 (ru)
UA (1) UA113722C2 (ru)
WO (1) WO2012071324A2 (ru)
ZA (1) ZA201303732B (ru)

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5688792A (en) 1994-08-16 1997-11-18 Pharmacia & Upjohn Company Substituted oxazine and thiazine oxazolidinone antimicrobials
US5895663A (en) 1997-07-31 1999-04-20 L. Perrigo Company Pseudoephedrine hydrochloride extended-release tablets
US6451345B1 (en) * 2000-01-20 2002-09-17 Eurand Pharmaceuticals Ltd. Functional coating of linezolid microcapsules for taste-masking and associated formulation for oral administration
UY26615A1 (es) 2000-03-16 2001-10-25 Pfizer Prod Inc Inhibidor de la glucogeno fosforilasa.
PE20011088A1 (es) 2000-03-22 2001-10-04 Upjohn Co Tratamiento de infecciones del tracto urinario con oxazolidinonas antibacterianas
AU2001243243B2 (en) * 2000-03-22 2004-10-14 Pharmacia & Upjohn Company Oxazolidinone tablet formulation
JP2003535860A (ja) 2000-06-05 2003-12-02 ドン・ア・ファーム・カンパニー・リミテッド 新規なオキサゾリジノン誘導体及びその製造方法
UA82824C2 (ru) * 2000-06-21 2008-05-26 К'Юбіст Фармасьютікалз, Інк. Композиция и способ улучшения перорального всасывания противомикробных средств
JP2002241268A (ja) * 2000-12-11 2002-08-28 Takeda Chem Ind Ltd 水溶解性が改善された医薬組成物
US20040058956A1 (en) 2000-12-11 2004-03-25 Yohko Akiyama Pharmaceutical composition having an improved water solubility
PL1656370T3 (pl) 2003-06-03 2013-03-29 Melinta Subsidiary Corp Biarylowe związki heterocykliczne oraz sposoby ich wytwarzania i stosowania
EP1713785A1 (en) 2003-12-17 2006-10-25 Rib-X Pharmaceuticals, Inc. Halogenated biaryl heterocyclic compounds and methods of making and using the same
KR100854211B1 (ko) 2003-12-18 2008-08-26 동아제약주식회사 신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물
TW200534879A (en) * 2004-03-25 2005-11-01 Bristol Myers Squibb Co Coated tablet formulation and method
AU2006242535B2 (en) * 2005-04-29 2012-08-09 Merck Sharp & Dohme Corp. Therapeutic compositions
US10532028B2 (en) 2005-07-28 2020-01-14 Isp Investments Llc Method to improve characteristics of spray dried powders and granulated materials, and the products thereby produced
WO2007014392A2 (en) 2005-07-28 2007-02-01 Isp Investments Inc. Benzoquinones of enhanced bioavailability
US20070104785A1 (en) * 2005-07-29 2007-05-10 Navale Suryakant V Tablets of linezolid form iii and processes for their preparation
JP5773560B2 (ja) 2006-02-09 2015-09-02 メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． Ｃｅｔｐ阻害剤のポリマー製剤
CL2007002331A1 (es) * 2006-08-10 2008-04-18 Cipla Ltd Composicion oral solida que comprede uno o mas farmacos antirretrovirales y al menos un polimero insoluble en agua, en relacion aproximadamente 1:1 hasta 1:6; proceso de elaboracion; y uso para el tratamiento del vih.
US20120208857A1 (en) * 2009-10-13 2012-08-16 Burak Eric S Pharmaceutical Compositions
CN103153343B (zh) * 2010-06-14 2015-02-11 陶氏环球技术有限责任公司 具有提高的醋酸酯和琥珀酸酯取代的醋酸羟丙基甲基纤维素琥珀酸酯
CA2816077C (en) * 2010-11-01 2021-08-10 Rib-X Pharmaceuticals, Inc. Antimicrobial compositions comprising an emulsifier and dissolution aid

Also Published As

Publication number Publication date
EA027791B1 (ru) 2017-09-29
EP2642996A2 (en) 2013-10-02
JP6370550B2 (ja) 2018-08-08
WO2012071324A2 (en) 2012-05-31
MX350565B (es) 2017-09-11
MX2013005813A (es) 2013-09-13
SG190354A1 (en) 2013-06-28
JP2017081950A (ja) 2017-05-18
EP2642996B1 (en) 2020-09-23
KR20140033314A (ko) 2014-03-18
UA113722C2 (uk) 2017-03-10
NZ610638A (en) 2015-05-29
ES2836809T3 (es) 2021-06-28
IL226378A0 (en) 2013-07-31
SG10201509530YA (en) 2015-12-30
BR112013012833A2 (pt) 2016-08-23
MY171941A (en) 2019-11-08
AU2011332031A1 (en) 2013-06-06
AU2011332031B2 (en) 2017-01-12
CA2818249A1 (en) 2012-05-31
CA2818249C (en) 2021-04-13
JP2013543893A (ja) 2013-12-09
BR112013012833A8 (pt) 2018-01-02
EP2642996A4 (en) 2014-05-21
PT2642996T (pt) 2020-12-30
HUE052801T2 (hu) 2021-05-28
US20160374995A1 (en) 2016-12-29
KR101944124B1 (ko) 2019-01-30
CN103391778B (zh) 2016-04-20
ZA201303732B (en) 2018-12-19
US10300046B2 (en) 2019-05-28
MY182136A (en) 2021-01-18
CN103391778A (zh) 2013-11-13
US20140088164A1 (en) 2014-03-27
WO2012071324A3 (en) 2012-08-16

Similar Documents

Publication Publication Date Title
IN2015DN01156A (ru)
TR201813877T4 (tr) Spi̇nal müsküler atrofi̇ni̇n tedavi̇ edi̇lmesi̇ne yöneli̇k bi̇leşi̇kler.
EA201491412A1 (ru) Соединения для лечения спинальной мышечной атрофии
EA201491766A1 (ru) Соединения для лечения спинальной мышечной атрофии
PH12015501609A1 (en) Phenicol antibacterials
MY188960A (en) Cyclic boronic acid ester derivatives and therapeutic uses thereof
EA201390198A1 (ru) Гетероциклическое соединение
EA201500383A1 (ru) Производные 1,2,4-триазина для лечения вирусных инфекций
MX2013003635A (es) Compuestos de n-heteroarilo.
SG10201900541QA (en) Derivatives of xanthone compounds
EA032271B9 (ru) Вещества, фармацевтическая композиция и методы применения при лечении воспалительных заболеваний
EA201270728A1 (ru) Пуриновые соединения
UA107346C2 (en) Use of nifuratel to treat infections caused by atopobium species
MX2015001834A (es) Nuevos compuestos antibacterianos.
MX363480B (es) Compuestos bacterianos que constan de un grupo heterocicloalquilo basado en nitrógeno que contiene un doble enlace unido a carbonilo que inhiben la enzima fabi.
IN2015DN02109A (ru)
IN2014DN03010A (ru)
EA201270547A1 (ru) Фармацевтическая композиция
MX2015015251A (es) Derivados de la quinolona.
PH12015502703A1 (en) Pharmaceutical compositions
EA201591192A1 (ru) Антибактериальные соединения
MX360040B (es) Nuevo agente antibacteriano derivado de florfenicol unido a sulfoximina y el uso del mismo en el tratamiento de infecciones bacterianas en ganado vacuno.
EA201390764A1 (ru) Фармацевтические композиции
IN2014KN02584A (ru)
EA201270727A1 (ru) Пуриновые соединения

Legal Events

Date Code Title Description
PD4A Registration of transfer of a eurasian patent in accordance with the succession in title
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU